| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
Julie Kim
|
||||||||
| GSM8121326 |
ARK2 cells, Control1, 24 hr
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8121327 |
ARK2 cells, Control2, 24 hr
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8121328 |
ARK2 cells, Control3, 24 hr
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8121329 |
ARK2 cells, Control4, 24 hr
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8121330 |
ARK2 cells, Control5, 24 hr
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8121331 |
ARK2 cells, Control6, 24 hr
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8121332 |
ARK2 cells, PAX8KD1, 24 hr
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8121333 |
ARK2 cells, PAX8KD2, 24 hr
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8121334 |
ARK2 cells, PAX8KD3, 24 hr
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8121335 |
ARK2 cells, PAX8KD4, 24 hr
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8121336 |
ARK2 cells, PAX8KD5, 24 hr
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8121337 |
ARK2 cells, PAX8KD6, 24 hr
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8122331 |
patient 1 tumor
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8122332 |
patient 2 tumor
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8122333 |
patient 3 tumor
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8122334 |
patient 4 tumor
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8122335 |
patient 5 tumor
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8122336 |
patient 6 tumor
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8122337 |
patient 7 tumor
|
SRA | 1 | Julie Kim | Sep 13, 2024 | ||||
| GSM8122338 |
patient 8 tumor
|
SRA | 1 | Julie Kim | Sep 13, 2024 |
